Startups

Brightmind.AI logo

Brightmind.AI

Vienna, Austria

Brightmind.AI GmbH is an Austrian neurotechnology company incorporated on September 16, 2022, developing personalized, non-invasive transcranial magnetic stimulation combined with EEG feedback and machine learning. Its initial research focus is migraine prevention, with professional-use and home-use device development described on its website; broader neurological applications are research ambitions. Its published roadmap does not establish regulatory approval, completed clinical efficacy trials or a commercial launch. The legal entity is registered in Vienna under FN 588896z, VAT ATU78525678. The official Austrian register records an insolvency publication in July 2025 and insolvency administrator Dr. Christian Bachmann, while continuing to list the entity as registered. The website’s leadership and adviser roster is documented as published affiliations; continuing operational tenure after the insolvency is unverified. ISTcube, now XISTA Science Ventures, announced an undisclosed foundational pre-seed investment in September 2022. The same primary announcement describes an EUR800,000 aws Seed award; full cash disbursement is not established. The company separately reports EUR3.3M cumulative funding including EUR2.4M combined non-dilutive support from aws and FFG, without dated individual allocations. Its statement that it was selected for a University of Oxford investment is not proof of a completed financing or a specific Oxford legal vehicle.

Founded 2022

Team

Christian BachmannChristian BachmannInsolvency Administrator (registered July2025)
Christian WindischbergerChristian WindischbergerAdvisor — Science & Engineering
Florian Lerchbammer-KreithFlorian Lerchbammer-KreithAdvisor — Advising Co-Founder
Gregor BrössnerGregor BrössnerAdvisor — Clinical Doctor & Migraine Expert
Gregor KowarikGregor KowarikCo-Founder & CTO
Iain StricklandIain StricklandAdvisor — Neuromodulation & Commercialization
Ingo SchroeterIngo SchroeterAdvisor — Strategy & Product
Ingrid KellyIngrid KellyAdvisor — IP & Investor
Jennifer BermanJennifer BermanAdvisor — Go-to-Market in Migraine
Johannes FrankRegistered Shareholder (since November2023)
Peter McAllisterPeter McAllisterAdvisor — Neurologist & Headache Expert
Rand AlmajidyRand AlmajidyMedical Engineer
René GilvertRené GilvertCo-Founder & CEO
Shivang JoshiShivang JoshiAdvisor — Neurologist & Headache Expert
Stan WoodsStan WoodsAdvisor — Consulting Director for Engineering
Tamara GerbertTamara GerbertFounder, VP of Strategy & Director of Neuroscience
Tibor ZechmeisterTibor ZechmeisterAdvisor — Regulatory

Investments